CCM
Catapult Capital Management Portfolio holdings
AUM
$193M
This Quarter Return
+4.7%
1 Year Return
+19.4%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$569M
AUM Growth
+$569M
(-9.5%)
Cap. Flow
-$64M
Cap. Flow
% of AUM
-11.26%
Top 10 Holdings %
Top 10 Hldgs %
27.83%
Holding
301
New
82
Increased
34
Reduced
57
Closed
85
Top Buys
| 1 |
Zoetis
ZTS
|
$23.5M |
| 2 |
PepsiCo
PEP
|
$12.8M |
| 3 |
AbbVie
ABBV
|
$10.4M |
| 4 |
Elevance Health
ELV
|
$9.85M |
| 5 |
Abbott
ABT
|
$8.59M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$21.5M |
| 2 |
Pfizer
PFE
|
$18M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$12.5M |
| 4 |
Pediatrix Medical
MD
|
$11.5M |
| 5 |
Danaher
DHR
|
$11.1M |
Sector Composition
| 1 | Healthcare | 52.24% |
| 2 | Consumer Discretionary | 10.35% |
| 3 | Industrials | 8.88% |
| 4 | Consumer Staples | 6.22% |
| 5 | Communication Services | 4.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Zoetis
ZTS
$69.3B
| $23.5M | 3.37% | +486,665 | New | +$23.5M |
|
2
CVS Health
CVS
$92.8B
| $20.7M | 2.97% | 196,947 +80,336 | +69% | +$8.43M |
|
|
3
AbbVie
ABBV
$372B
| $18.1M | 2.61% | 270,000 +155,000 | +135% | +$10.4M |
|
4
Edwards Lifesciences
EW
$47.8B
| $17.2M | 2.48% | 120,953 +20,953 | +21% | +$2.98M |
|
|
SHPG
5
DELISTED
Shire pic
SHPG
| $15.3M | 2.19% | 63,255 +18,255 | +41% | +$4.41M |
|
6
DaVita
DVA
$9.85B
| $13.9M | 2% | 175,100 +33,774 | +24% | +$2.68M |
|
|
7
PepsiCo
PEP
$204B
| $12.8M | 1.84% | +137,074 | New | +$12.8M |
|
8
Universal Health Services
UHS
$11.6B
| $12.8M | 1.84% | 90,000 +40,000 | +80% | +$5.68M |
|
9
McKesson
MCK
$85.4B
| $12.4M | 1.78% | 55,000 +21,017 | +62% | +$4.73M |
|
|
MNK
10
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $11.6M | 1.67% | 98,715 -106,225 | -52% | -$12.5M |
|
|
ESRX
11
DELISTED
Express Scripts Holding Company
ESRX
| $11.1M | 1.6% | 125,000 +50,000 | +67% | +$4.45M |
|
|
12
Elevance Health
ELV
$71.8B
| $9.85M | 1.42% | +60,000 | New | +$9.85M |
|
|
13
Abbott
ABT
$231B
| $8.59M | 1.23% | +175,000 | New | +$8.59M |
|
14
Gilead Sciences
GILD
$140B
| $8.29M | 1.19% | +70,800 | New | +$8.29M |
|
15
Meta Platforms (Facebook)
META
$1.86T
| $6.85M | 0.98% | 79,880 +1,210 | +2% | +$104K |
|
16
Humana
HUM
$36.5B
| $6.7M | 0.96% | 35,000 -15,000 | -30% | -$2.87M |
|
17
Thermo Fisher Scientific
TMO
$186B
| $6.49M | 0.93% | +50,000 | New | +$6.49M |
|
|
AET
18
DELISTED
Aetna Inc
AET
| $6.37M | 0.92% | +50,000 | New | +$6.37M |
|
19
McDonald's
MCD
$224B
| $6.29M | 0.9% | 66,200 -10,812 | -14% | -$1.03M |
|
|
ADPT
20
DELISTED
Adeptus Health Inc.
ADPT
| $6.17M | 0.89% | 65,000 +15,000 | +30% | +$1.42M |
|
|
21
Teva Pharmaceuticals
TEVA
$21.1B
| $6.08M | 0.87% | 102,831 -363,908 | -78% | -$21.5M |
|
22
Perrigo
PRGO
$3.27B
| $5.93M | 0.85% | +32,057 | New | +$5.93M |
|
23
Hanesbrands
HBI
$2.23B
| $5.61M | 0.81% | 168,455 -5,285 | -3% | -$176K |
|
24
Conagra Brands
CAG
$9.16B
| $5.39M | 0.77% | +123,351 | New | +$5.39M |
|
|
THOR
25
DELISTED
THORATEC CORPORATION
THOR
| $5.37M | 0.77% | 120,533 -79,467 | -40% | -$3.54M |
|